Cosmid vector for F/RGD fiber mutant Adv construction
Clone info. | Shuttle vector to make recombinant adenovirus with chimeric fiber F/RGD. |
---|---|
Vector backbone | pWE15 (Cosmid, use packaging extracts for transforming E. coli host) |
Size of vector backbone | 39.4 kb |
Selectable markers | Amp^r |
Gene/insert name | AdV_5 whole genome Genomic DNA |
Depositor|Developer | Hamada, Hirofumi | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested.(Hum. Gene Ther., 13, 613-626 (2002); Mol. Ther., 7, 354-365 (2003).) In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. |
Remarks | Remember that you will be working with samples containing infectious virus. |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 非営利機関の非営利学術研究へ提供する。利用者が本件リソースを利用した研究成果に基づき特許申請、商業活動等を行う場合は、利用者は事前に寄託者に連絡する。利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する(Hum. Gene Ther., 13, 613-626 (2002); Mol. Ther., 7, 354-365 (2003).)。利用者は、研究成果の公表にあたって謝辞の表明を必要とする。 |
備考 | このリソースはウイルス粒子産生用のため、取扱いに注意が必要です。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB03952 | pWEAx-FRGD | DNA solution |
JPY 9,460 (not-for-profit academic purpose) plus cost of shipping containers, dry ice (if required) and shipping charge |
Materials & Methods section:
The pWEAx-FRGD was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB03952). |
Reference section:
Tsuda, H., Wada, T., Ito, Y., Uchida, H., Dehari, H., Nakamura, K., Sasaki, K., Kobune, M., Yamashita, T., Hamada, H., Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. Mol. Ther., 7, 354-365 (2003). PMID 12668131. |
Nakamura, T., Sato, K., Hamada, H., Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors. Hum. Gene Ther., 13, 613-626 (2002). PMID 11916485. |
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB03952_A9Fap1-2.pdf ![]() |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: pAxcwit2-Fw (Pr0134) Region: Ad5 psi,ITR(truncated),AmpR pro Sequence file: RDB03952_A9Faa.seq ![]() |
---|
>03952_03952_A9Fa_1_pAxcwit2_Fw_E05_14_ABI24.ab1 1 NNNNNNNNNN NNNNNNNNNN NNNNNNNCNA GTGNNCGGGC CTCAGCTCCT CGGTCACATC 61 CAGCATCACA GGCTGGTTCC TAATATGTTT ACCGCCACAC TCGCAGGGTC TGCACCTGGT 121 GCGGGTCTCA TCGTACCTCA GCACCTTCCA GATCCATCGT CGCGAGTCGA CAATCGATTT 181 AAATCGATGC TGACTATAAT AATAAAACGC CAACTTTGAC CCGGAACGCG GAAAACACCT 241 GAGAAAAACA CCTGGGCGAG TCTCCACGTA AACGGTCAAA GTCCCCGCGG CCCTAGACAA 301 ATATTACGCG CTATGAGTAA CACAAAATTA TTCAGATTTC ACTTCCTCTT ATTCAGTTTT 361 CCCGCGAAAA TGGCCAAATC TTACTCGGTT ACGCCCAAAT TTACTACAAC ATCCGCCTAA 421 AACCGCGCGA AAATTGTCAC TTCCTGTGTA CACCGGCGCA CACCAAAAAC GTCACTTTTG 481 CCACATCCGT CGCTTACATG TGTTCCGCCA CACTTGCAAC ATCACACTTC CGCCACACTA 541 CTACGTCACC CGCCCCGTTC CCACGCCCCG CGCCACGTCA CAAACTCCAC CCCCTCATTA 601 TCATATTGGC CCGGATCCGG AATTCTTGAA GACGAAAGGG CCTCGTGATA CGCCTATTTT 661 TATAGGTTAA TGTCATGATA ATAATGGTTT CTTAGACGTC AGGTGGCACT TTTCGGGGAA 721 ATGTGCGCGG AACCCCTATT TGTTTATTTT TCTAAATACA TTCAAATATG TATCCGCTCA 781 TGAGACAATA ACCCTGATAA ATGCTTCAAT AATATTGAAA AAGGAAGAGT ATGAGTATTC 841 AACATTTCCG TGTCGCCCTT ATTCCCTTTT TTTGCGGCAT TTTGCCTTCC TGTTTTTGCT 901 CACCNAGAAA CGCTGGTGAA AGTAAAAGAN GCTGAAGNTC AGTTNGGNGC ACNAGNGGGN 961 TNNATCNAAC TGGNTNTCNN NNNCGGTNNN ATNCNTTNNN ANNTTTCGNC NNNNANNNNN 1021 NNTTTNNNNN NNNNN // |
Primer: fiber-M_F2 (Pr0638) Region: Fiber-RGD Sequence file: RDB03952_A9Fab.seq ![]() |
>03952_03952_A9Fa_1_fiber-M_F2_C02_08_ABI24.ab1 1 NNNNNNNNNN NNNNNNNNNG NNNNGCCTAT ACNAACGCTG TTGGNNTTAT GCCTAACCTA 61 TCAGCTTATC CAAAATCTCA CGGTAAAACT GCCAAAAGTA ACATTGTCAG TCAAGTTTAC 121 TTAAACGGAG ACAAAACTAA ACCTGTAACA CTAACCATTA CACTAAACGG TACACAGGAA 181 ACAGGAGACA CAACTTGTGA CTGCCGCGGA GACTGTTTCT GCCCAAGTGC ATACTCTATG 241 TCATTTTCAT GGGACTGGTC TGGCCACAAC TACATTAATG AAATATTTGC CACCTCGAGT 301 TACACTTTTT CATACATTGC CCAAGAATAA GGATCCACGC GTGTCGACAA GAATAAAGAA 361 TCGTTTGTGT TATGTTTCAA CGTGTTTATT TTTCAATTGC AGAAAATTTC AAGTCATTTT 421 TCATTCAGTA GTATAGCCCC ACCACCACAT AGCTTATACA GATCACCGTA CCTTAATCAA 481 ACTCACAGAA CCCTAGTATT CAACCTGCCA CCTCCCTCCC AACACACAGA GTACACAGTC 541 CTTTCTCCCC GGCTGGCCTT AAAAAGCATC ATATCATGGG TAACAGACAT ATTCTTAGGT 601 GTTATATTCC ACACGGTTTC CTGTCGAGCC AAACGCTCAT CAGTGATATT AATAAACTCC 661 CCGGGCAGCT CACTTAAGTT CATGTCGCTG TCCAGCTGCT GAGCCACAGG CTGCTGTCCA 721 ACTTGCGGTT GCTTAACGGG CGGCGAANGA GAAGTCCACG CCTACATGGG GGTAGAGTCA 781 TAATCGTGCA TCANGATAGG GCGGTGGTGC TGCAGCAGCG CGCGAATAAA CTGCTGCCGC 841 CGCCGCTCCG TCCTGCANGA ATACAACATG GCAGTGGTCT CCTCANCGAT GANTCGCACC 901 GCCCGCANCA TAAGGNGNNN TGNCCTNCGG GCACANCAGC NCACCCTGAT NTCACNTNAA 961 NTCAGCNCAG NAACNGCNNN NCANNNNNNN NNTNTTGTTC NAANNCCNNN ANNNNNNNNN 1021 N // |
Primer: Neo-M_F (Pr0147) Region: NeoR_KanR Sequence file: RDB03952_A9Fac.seq ![]() |
>03952_03952_B3B1F_1_Neo-M_F_E01_13_ABI24.ab1 1 NNNNNNNNNN NNANGGCTGN NGCNNNGCGG CGGCTGCATA CGCTTGATCC GGCTACCTGC 61 CCATTCGACC ACCAAGCGAA ACATCGCATC GAGCGAGCAC GTACTCGGAT GGAAGCCGGT 121 CTTGTCGATC AGGATGATCT GGACGAAGAG CATCAGGGGC TCGCGCCAGC CGAACTGTTC 181 GCCAGGCTCA AGGCGCGCAT GCCCGACGGC GAGGATCTCG TCGTGACCCA TGGCGATGCC 241 TGCTTGCCGA ATATCATGGT GGAAAATGGC CGCTTTTCTG GATTCATCGA CTGTGGCCGG 301 CTGGGTGTGG CGGACCGCTA TCAGGACATA GCGTTGGCTA CCCGTGATAT TGCTGAAGAG 361 CTTGGCGGCG AATGGGCTGA CCGCTTCCTC GTGCTTTACG GTATCGCCGC TCCCGATTCG 421 CAGCGCATCG CCTTCTATCG CCTTCTTGAC GAGTTCTTCT GAGCGGGACT CTGGGGTTCG 481 AAATGACCGA CCAAGCGACG CCCAACCTGC CATCACGAGA TTTCGATTCC ACCGCCGCCT 541 TCTATGAAAG GTTGGGCTTC GGAATCGTTT TCCGGGACGC CGGCTGGATG ATCCTCCAGC 601 GCGGGGATCT CATGCTGGAG TTCTTCGCCC ACCCCGGGCT CGATCCCCTC GCGAGTTGGT 661 TCAGCTGCTG CCTGANGCTG GACGACCTCG CGGAGTTCTA CCGGCAGTGC AAATCCGTCN 721 GCATCCAGGA AACCAGCAGC GGCTATCCGC GCATCCATGC CCCCGAACTG CANGAGTGGN 781 GAGGCACGAT GGCCGCTTTG GNCCGGATCT TTGTGAAGGA NCCTTACTTC TGTGGTGTGA 841 CATANTTGGA CAAACTACCT ACNGANNNTT AAAGCTCTNA GGNAAATANA AAATTTTNAA 901 GTGNATNATG TGTTAAACTA CNGATTCTNN TTGNTTGTGT ATTTTANANT NNNNCNNANN 961 NNNNTGNNGN ANGGNNNCNG NNNNNGNNNN NNNNTNNNNN NNNAAANNNN NNTNNNNNNN 1021 NNN // |
Primer: Neo-B_R (Pr0911) Region: NeoR_KanR,SV40 pro_ori Sequence file: RDB03952_A9Fad.seq ![]() |
>03952_03952_B3B1F_1_Neo-B_R_F01_16_ABI24.ab1 1 NNNNNNNNNN NNNNNNNNNN NNNNNTGCGT GCNATCNNTC TTGTTCNATC ATGCGAAACG 61 ATCCTCATCC TGTCTCTTGA TCAGATCTTG ATCCCCTGCG CCATCAGATC CTTGGCGGCA 121 AGAAAGCCAT CCAGTTTACT TTGCAGGGCT TCCCAACCTT ACCAGAGGGC GCCCCAGCTG 181 GCAATTCCGG TTCGCTTGCT GTCCATAAAA CCGCCCAGTC TAGCTATCGC CATGTAAGCC 241 CACTGCAAGC TACCTGCTTT CTCTTTGCGC TTGCGTTTTC CCTTGTCCAG ATAGCCCAGT 301 AGCTGACATT CATCCGGGGT CAGCACCGTT TCTGCGGACT GGCTTTCTAC GTGTTCCGCT 361 TCCTTTAGCA GCCCTTGCGC CCTGAGTGCT TGCGGCAGCG TGAAGCTTTT TGCAAAAGCC 421 TAGGCCTCCA AAAAAGCCTC CTCACTACTT CTGGAATAGC TCAGAGGCCG AGGCGGCCTC 481 GGCCTCTGCA TAAATAAAAA AAATTAGTCA GCCATGGGGC GGAGAATGGG CGGAACTGGG 541 CGGAGTTAGG GGCGGGATGG GCGGAGTTAG GGGCGGGACT ATGGTTGCTG ACTAATTGAG 601 ATGCATGCTT TGCATACTTC TGCCTGCTGG GGAGCCTGGG GACTTTCCAC ACCTGGTTGC 661 TGACTAATTG AGATGCATGC TTTGCATACT TCTGCCTGCT GGGGAGCCTG GGGACTTTCC 721 ACACCCTAAC TGACACACAT TCCACAGCCG GATCTGCAGG ANCCAACGCT GCCCGAGANG 781 CGCCGCGTGC GGCTGCTGGA NATGGCGGAN GCGATGGATA TGTTCTGCCN AGGGTTGGTT 841 TGCGCATTCA CAGTTCTCCG CAAGAANTGA TTGGCTNCNA TTCTTGGANT GGTGAATNCG 901 TTANCGAGGN GCCGCCNGCT TCCNTNCNNN CGAGGNGGNC CGGCNNCNNN NNNNNNGNNG 961 CNNNNCGGGG NNNCNNANNN NNNNNANGGN NGNNNNNTAN NNNNNNNNN // |
Primer: AxIT_R (Pr0347) Region: ITR,cos 3' Sequence file: RDB03952_A9Fae.seq ![]() |
>03952_03952_A9Fa_1_AxIT_R_F05_17_ABI24.ab1 1 NNNNNNNNNN NNNNNNNNNN NAAGCCNNAA AACCCACAAC TTCCTCAAAT CGTCACTTCC 61 GTTTTCCCAC GTTACGTCAC TTCCCNTTTT AAGAAAACTA CAATTCCCAA CACATACAAG 121 TTACTCCGCC CTAAAACCTA CGTCACCCGC CCCGTTCCCA CGCCCCGCGC CACGTCACAA 181 ACTCCACCCC CTCATTATCA TATTGGCTTC AATCCAAAAT AAGGTATATT ATTGATGATG 241 AAGCTTGGTT AATTAACGTT AATTAACCGG CGGCCGCCAC CGCTTCGATA AGCTTTAATG 301 CGGTAGTTTA TCACAGTTAA ATTGCTAACG CAGTCAGGCA CCGTGTATGA AATCTAACAA 361 TGCGCTCATC GTCATCCTCG GCACCGTCAC CCTGGATGCT GTAGGCATAG GCTTGGTTAT 421 GCCGGTACTG CCGGGCCTCT TGCGGGATAT CGTCCATTCC GACAGCATCG CCAGTCACTA 481 TGGCGTGCTG CTAGCGCTAT ATGCGTTGAT GCAATTTCTA TGCGCACCCG TTCTCGGAGC 541 ACTGTCCGAC CGCTTTGGCC GCCGCCCAGT CCTGCTCGCT TCGCTACTTG GAGCCACTAT 601 CGACTACGCG ATCATGGCGA CCACACCCGT CCTGTGGATC TGCCTCGCTG GCCTGCCGCA 661 GTTCTTCAAC CTCCCGGCGC AGCTTTTCGT TCTCAATTTC AGCATCCCTT TCGGCATACC 721 ATTTTATGAC GGCGGCAGAG TCATAAAGCA CCTCATTACC CTTGCCACCG CCTCGCAGAA 781 CGGGCATTCC CTGTTCCTGC CAGTTCTGAA TGGTANGGAT ACTCGCACCG AAAATGTCAG 841 CCAGCTGCTT TTTGTTGANT TCCATTGTNC ANTCCACGGN NNAAAACAGA GAAAGGAANN 901 GACAGANGCC AAAAAGCTCG CTTTCAGCAC CNGTCGTTTC CTTTCNTTTN ANANGGNATT 961 TTNAATNAAA ACNTTAANTT ATGANGANNN NNNNNNN // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
original | Tsuda, H., Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. Mol. Ther., 7, 354-365 (2003). PMID 12668131. |
---|---|
original | Nakamura, T., Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors. Hum. Gene Ther., 13, 613-626 (2002). PMID 11916485. |
Featured content